Related Experiment Video
Updated: Jul 19, 2026
Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy
Published on: September 17, 2017
Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations
Matthew M Dedmon1, Kresten Lindorff-Larsen, John Christodoulou
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
Parkinson's disease involves alpha-synuclein protein. Its native structure, partially condensed, may prevent toxic aggregate formation, offering a new therapeutic target for Parkinson's disease.
Area of Science:
- Biochemistry
- Neuroscience
- Protein Chemistry
Background:
- Alpha-synuclein is intrinsically disordered and central to Parkinson's disease pathogenesis.
- Protein aggregation is a hallmark of neurodegenerative diseases like Parkinson's.
Purpose of the Study:
- To investigate the native structural ensemble of alpha-synuclein.
- To understand the structural basis of alpha-synuclein's role in Parkinson's disease.
Main Methods:
- Hydrodynamic radius measurements.
- Analysis of protein sequence and charge distribution.
Main Results:
- Native alpha-synuclein exists as a distribution of conformers, not a random coil.
- A partially condensed structure was observed, smaller than a random coil.
- This structure arises from C-terminus charge and central hydrophobic region interactions.
Conclusions:
- The native, partially condensed structure of alpha-synuclein may inhibit toxic aggregation.
- This finding offers potential new therapeutic strategies for Parkinson's disease.
More Related Videos
07:56Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time
Published on: May 30, 2021
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
